vs
Consolidated Water Co. Ltd.（CWCO）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Consolidated Water Co. Ltd.的1.2倍（$35.5M vs $29.6M），Consolidated Water Co. Ltd.净利率更高（10.3% vs -304.2%，领先314.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 4.4%），Consolidated Water Co. Ltd.自由现金流更多（$3.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -13.6%）
可口可乐联合装瓶公司总部位于美国北卡罗来纳州夏洛特市，是美国规模最大的独立可口可乐装瓶企业，主要承担可口可乐系列饮品的生产装瓶、仓储配送与市场销售业务，在美国本土饮品供应链中占据重要地位。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CWCO vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $29.6M | $35.5M |
| 净利润 | $3.0M | $-108.1M |
| 毛利率 | 34.7% | 59.8% |
| 营业利润率 | 9.1% | -304.8% |
| 净利率 | 10.3% | -304.2% |
| 营收同比 | 4.4% | 681.7% |
| 净利润同比 | 91.5% | 39.6% |
| 每股收益（稀释后） | $0.18 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $29.6M | $35.5M | ||
| Q3 25 | $35.1M | $5.2M | ||
| Q2 25 | $33.6M | $19.2M | ||
| Q1 25 | $33.7M | $14.7M | ||
| Q4 24 | $28.4M | $4.5M | ||
| Q3 24 | $33.4M | $26.1M | ||
| Q2 24 | $32.5M | $14.4M | ||
| Q1 24 | $39.7M | $13.8M |
| Q4 25 | $3.0M | $-108.1M | ||
| Q3 25 | $5.5M | $-162.3M | ||
| Q2 25 | $5.1M | $-171.9M | ||
| Q1 25 | $4.8M | $-202.5M | ||
| Q4 24 | $1.6M | $-178.9M | ||
| Q3 24 | $4.5M | $-95.8M | ||
| Q2 24 | $15.9M | $-97.5M | ||
| Q1 24 | $6.5M | $-91.4M |
| Q4 25 | 34.7% | 59.8% | ||
| Q3 25 | 36.9% | -183.8% | ||
| Q2 25 | 38.2% | -4.9% | ||
| Q1 25 | 36.5% | -48.0% | ||
| Q4 24 | 29.9% | -181.4% | ||
| Q3 24 | 34.8% | 53.7% | ||
| Q2 24 | 35.8% | 36.2% | ||
| Q1 24 | 35.0% | 19.1% |
| Q4 25 | 9.1% | -304.8% | ||
| Q3 25 | 16.4% | -3327.6% | ||
| Q2 25 | 15.7% | -916.8% | ||
| Q1 25 | 13.7% | -1297.9% | ||
| Q4 24 | 3.8% | -4042.4% | ||
| Q3 24 | 14.6% | -377.1% | ||
| Q2 24 | 15.4% | -697.4% | ||
| Q1 24 | 18.4% | -698.4% |
| Q4 25 | 10.3% | -304.2% | ||
| Q3 25 | 15.8% | -3135.3% | ||
| Q2 25 | 15.2% | -894.2% | ||
| Q1 25 | 14.2% | -1373.3% | ||
| Q4 24 | 5.6% | -3935.5% | ||
| Q3 24 | 13.3% | -367.5% | ||
| Q2 24 | 48.8% | -676.6% | ||
| Q1 24 | 16.3% | -662.4% |
| Q4 25 | $0.18 | $-0.17 | ||
| Q3 25 | $0.34 | $-0.36 | ||
| Q2 25 | $0.32 | $-0.41 | ||
| Q1 25 | $0.30 | $-0.50 | ||
| Q4 24 | $0.10 | $-0.56 | ||
| Q3 24 | $0.28 | $-0.34 | ||
| Q2 24 | $0.99 | $-0.40 | ||
| Q1 24 | $0.40 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $123.8M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $221.7M | $1.1B |
| 总资产 | $257.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $123.8M | $743.3M | ||
| Q3 25 | $123.6M | $659.8M | ||
| Q2 25 | $112.2M | $525.1M | ||
| Q1 25 | $107.9M | $500.5M | ||
| Q4 24 | $99.4M | $594.4M | ||
| Q3 24 | $104.9M | $427.6M | ||
| Q2 24 | $96.7M | $474.3M | ||
| Q1 24 | $46.2M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $221.7M | $1.1B | ||
| Q3 25 | $220.4M | $1.0B | ||
| Q2 25 | $216.6M | $919.1M | ||
| Q1 25 | $213.3M | $933.9M | ||
| Q4 24 | $210.0M | $1.0B | ||
| Q3 24 | $209.8M | $524.6M | ||
| Q2 24 | $206.7M | $584.4M | ||
| Q1 24 | $192.1M | $401.2M |
| Q4 25 | $257.6M | $1.5B | ||
| Q3 25 | $257.2M | $1.4B | ||
| Q2 25 | $257.5M | $1.3B | ||
| Q1 25 | $250.4M | $1.3B | ||
| Q4 24 | $243.3M | $1.4B | ||
| Q3 24 | $238.4M | $726.5M | ||
| Q2 24 | $235.2M | $775.9M | ||
| Q1 24 | $223.2M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 11.4% | -133.1% |
| 资本支出强度资本支出/营收 | 8.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 1.90× | — |
| 过去12个月自由现金流最近4个季度 | $33.2M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $5.8M | $-46.1M | ||
| Q3 25 | $15.4M | $-117.4M | ||
| Q2 25 | $8.8M | $-76.4M | ||
| Q1 25 | $11.8M | $-132.0M | ||
| Q4 24 | $-742.0K | $-115.4M | ||
| Q3 24 | $10.4M | $-59.2M | ||
| Q2 24 | $21.0M | $-82.2M | ||
| Q1 24 | $6.0M | $-102.3M |
| Q4 25 | $3.4M | $-47.3M | ||
| Q3 25 | $13.5M | $-117.6M | ||
| Q2 25 | $6.1M | $-79.6M | ||
| Q1 25 | $10.2M | $-133.8M | ||
| Q4 24 | $-3.7M | $-116.7M | ||
| Q3 24 | $8.3M | $-63.8M | ||
| Q2 24 | $19.8M | $-83.4M | ||
| Q1 24 | $5.4M | $-109.0M |
| Q4 25 | 11.4% | -133.1% | ||
| Q3 25 | 38.4% | -2272.5% | ||
| Q2 25 | 18.3% | -413.9% | ||
| Q1 25 | 30.1% | -907.4% | ||
| Q4 24 | -13.0% | -2567.7% | ||
| Q3 24 | 24.9% | -244.6% | ||
| Q2 24 | 60.8% | -578.5% | ||
| Q1 24 | 13.7% | -789.9% |
| Q4 25 | 8.1% | 3.5% | ||
| Q3 25 | 5.5% | 4.7% | ||
| Q2 25 | 7.8% | 16.4% | ||
| Q1 25 | 4.7% | 12.4% | ||
| Q4 24 | 10.4% | 28.6% | ||
| Q3 24 | 6.1% | 17.5% | ||
| Q2 24 | 3.7% | 8.2% | ||
| Q1 24 | 1.3% | 48.2% |
| Q4 25 | 1.90× | — | ||
| Q3 25 | 2.79× | — | ||
| Q2 25 | 1.72× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | -0.47× | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 1.32× | — | ||
| Q1 24 | 0.92× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CWCO
| Services Revenues | $10.5M | 35% |
| Transferred At Point In Time | $8.5M | 29% |
| Operations And Maintenance | $8.4M | 28% |
| Transferred Over Time | $1.9M | 7% |
RXRX
暂无分部数据
